SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
AMN Healthcare announced that it has named industry veteran Darren Findley as vice president of recruitment process outsourcing.
Kleanthis Xanthopoulos, who has served more than seven years at the helm of San Diego microRNA drug developer Regulus Therapeutics, unexpectedly resigned as CEO and from the company’s board, according to a statement from the company.
Neurocrine Biosciences Inc. announced that Eric Benevich has joined the company as chief commercial officer.
Biocept Inc., a molecular diagnostics company developing liquid biopsies to improve the detection and treatment of cancer, entered into a clinical collaboration with Sarah Cannon Research Institute, the research arm of Sarah Cannon, the global cancer enterprise of Hospital Corp. of America.
Poseida Therapeutics Inc., a privately-held human therapeutics spinoff of Transposagen Biopharmaceuticals Inc., announced it has begun drug development operations at its new location at Johnson & Johnson Innovation, JLABS in San Diego.
La Mesa-based Entest BioMedical Inc. announced Tuesday that the company is in discussions to acquire a nanotechnology for the delivery of cancer therapeutics in both animals and humans.
San Diego-based Benefunder announced a partnership with Washington D.C.-based Children’s National Health System to boost funding for pediatric research.
San Diego drug developer Celladon Corp. has announced new leadership and plans to seek an acquisition or partnership.
San Diego-based Cypher Genomics Inc., a genome informatics company, and the Clinic for Special Children announced a collaboration in which Cypher's automated genomic interpretation tools will be used for the diagnosis of rare genetic diseases among a specific population.
BIOTECH: He Served As Life Technologies’ CEO for Many Years
NuVasive, Inc., a leading medical device company focused on transforming spine surgery with minimally invasive solutions, announced that Gregory T. Lucier has been appointed chief executive officer, effective immediately.
HEALTH: First Responders Bring Big Privacy Issues
When Scott Silverman looked for a drug treatment facility after years of addiction, the demographics of his fellow patients was not a pressing concern.
BIOTECH: Food Products, Supplements Are Options
Let’s be honest, biofuel was a bit of a bust.
Viking Therapeutics Inc., a clinical-stage biopharmaceutical company, announced Friday that the underwriters for its recent initial public offering have exercised their option to purchase from Viking an additional 450,000 shares at the initial offering price to the public of $8 per share.
Mast Therapeutics Inc., a biopharmaceutical company in San Diego, announced Thursday that Jack Lief will be resigning from the company's board of directors.
Medical-device maker Freedom Meditech Inc. announced Thursday that it has appointed John Gerace, most recently of Life Technologies, as its chief executive officer and a member of the company's board of directors.